NEW YORK (GenomeWeb News) — Swedish genetic and chemical-analysis company Biotage has made a move into the molecular-imaging market through a collaboration with McMaster University that relies on SPECT/CT and PET/CT imaging technologies, the company said today.
 
Biotage said it entered the collaboration with the Ontario-based research university in February, but did not disclose terms of the partnership.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.